Market Overview:
The global diphtheria toxoid market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The increasing incidence of diphtheria and the subsequent increase in demand for diphtheria toxoid are the major factors driving the growth of this market. Diphtheria is a life-threatening disease caused by Corynebacterium diphtheriae, which can lead to respiratory failure, heart failure, and death. The increasing awareness about the benefits of vaccination against diphtheria is also contributing to the growth of this market. The global diphtheria toxoid market can be segmented on the basis of type and application. On the basis of type, it can be divided into reducing toxin and denatured toxin. Reducing toxin is a more potent form than denatured toxin and has been used for immunization since 1924.
Product Definition:
A toxoid is a vaccine made from a toxin that has been inactivated (made unable to cause disease). Diphtheria toxoid is used to prevent diphtheria.
Reducing Toxin:
The reducing toxin is a protein that inhibits the functioning of an enzyme needed for the production of toxic proteins. The reduction in toxicity is achieved by two mechanisms, either by competition for substrate or inhibition of catalytic activity. In diphtheria toxin, it binds to receptor on cell membrane and leads to internalization and death of cells via lysosome pathway.
Denatured Toxin:
Denatured toxins are the most commonly used type of diphtheria toxin. They have a molecular weight between 10,000 and 3,200 Da. The name denatured is derived from the word “denature” which means to change or remove all strength or potency from a substance by heating it to very high temperatures (above 200oC).
Application Insights:
The global diphtheria toxoid market is segmented on the basis of application into hospitals, clinics, and ambulatory surgical centers. The hospital segment dominated the overall market in terms of revenue in 2017 owing to high usage rates of diphtheria toxoid across various parts of the world. In addition, an increase in spending on healthcare coupled with growing awareness about immunization is expected to drive growth over the forecast period.
The clinic segment is anticipated to witness significant growth during the forecast period due to rising awareness about immunization against a number of diseases including diphtheria along with increasing spending on healthcare by consumers globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of a strong healthcare infrastructure and high disease prevalence are some of the major factors contributing to its growth. Moreover, introduction and wide implementation of diphtheria-toxoid immunization programs is expected to further fuel revenue generation in this region.
Asia Pacific is estimated to be the fastest-growing regional market over the forecast period owing to rising awareness about diphtheria vaccination coupled with increasing access for children under five years of age as well as adults above 65 years old population group in India, China, Indonesia, Malaysia and other countries. In addition, growing medical tourism industry due to availability of advanced treatment at cheaper costs will also drive demand for toxoids over next eight years.
Growth Factors:
- Increasing incidence of diphtheria: The incidence of diphtheria is increasing globally due to various factors such as lack of awareness, unhygienic conditions, and improper immunization. This is expected to drive the demand for Diphtheria toxoid vaccine in the coming years.
- Growing number of travelers: The number of travelers is increasing every year, which is resulting in an increase in the spread of infectious diseases such as diphtheria. This is anticipated to boost the demand for Diphtheria toxoid vaccine over the forecast period.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as diabetes and cancer is rising globally, which has led to an increase in susceptibility to infections such as diphtheria. This will create a high demand for Diphtheria toxoid vaccine in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diphtheria Toxoid Market Research Report
By Type
Reducing Toxin, Denatured Toxin
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
Biocompare, GSK, Zoetis, Sanofi, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Diphtheria Toxoid Market Report Segments:
The global Diphtheria Toxoid market is segmented on the basis of:
Types
Reducing Toxin, Denatured Toxin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biocompare
- GSK
- Zoetis
- Sanofi
- Merck
Highlights of The Diphtheria Toxoid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reducing Toxin
- Denatured Toxin
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diphtheria Toxoid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diphtheria toxoid is a vaccine that helps protect people from diphtheria. It is made from the toxin of the bacterium that causes diphtheria, and it helps to prevent infection by this bacteria. Diphtheria toxoid is given as a shot in combination with other vaccines (such as tetanus and pertussis) to help protect against these diseases.
Some of the key players operating in the diphtheria toxoid market are Biocompare, GSK, Zoetis, Sanofi, Merck.
The diphtheria toxoid market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diphtheria Toxoid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diphtheria Toxoid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diphtheria Toxoid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diphtheria Toxoid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diphtheria Toxoid Market Size & Forecast, 2018-2028
4.5.1 Diphtheria Toxoid Market Size and Y-o-Y Growth
4.5.2 Diphtheria Toxoid Market Absolute $ Opportunity
Chapter 5 Global Diphtheria Toxoid Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diphtheria Toxoid Market Size Forecast by Type
5.2.1 Reducing Toxin
5.2.2 Denatured Toxin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diphtheria Toxoid Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diphtheria Toxoid Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diphtheria Toxoid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diphtheria Toxoid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diphtheria Toxoid Analysis and Forecast
9.1 Introduction
9.2 North America Diphtheria Toxoid Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diphtheria Toxoid Market Size Forecast by Type
9.6.1 Reducing Toxin
9.6.2 Denatured Toxin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diphtheria Toxoid Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diphtheria Toxoid Analysis and Forecast
10.1 Introduction
10.2 Europe Diphtheria Toxoid Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diphtheria Toxoid Market Size Forecast by Type
10.6.1 Reducing Toxin
10.6.2 Denatured Toxin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diphtheria Toxoid Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diphtheria Toxoid Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diphtheria Toxoid Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diphtheria Toxoid Market Size Forecast by Type
11.6.1 Reducing Toxin
11.6.2 Denatured Toxin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diphtheria Toxoid Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diphtheria Toxoid Analysis and Forecast
12.1 Introduction
12.2 Latin America Diphtheria Toxoid Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diphtheria Toxoid Market Size Forecast by Type
12.6.1 Reducing Toxin
12.6.2 Denatured Toxin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diphtheria Toxoid Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diphtheria Toxoid Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diphtheria Toxoid Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diphtheria Toxoid Market Size Forecast by Type
13.6.1 Reducing Toxin
13.6.2 Denatured Toxin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diphtheria Toxoid Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diphtheria Toxoid Market: Competitive Dashboard
14.2 Global Diphtheria Toxoid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biocompare
14.3.2 GSK
14.3.3 Zoetis
14.3.4 Sanofi
14.3.5 Merck
